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Abstract
Objectives: Testing and treatment are essential aspects of the delivery of emergency care. Recognition of
the effects of these activities on emergency department (ED) length of stay (LOS) has implications for admin-
istrators planning efficient operations, providers, and patients regarding expectations for length of visit;
researchers in creating bettermodels to predict LOS; and policy-makers concerned about ED crowding.
Methods: A secondary analysis was performed using years 2006 through 2008 of the National Hospital
AmbulatoryMedical Care Survey (NHAMCS), a nationwide study of ED services. In univariate and bivariate
analyses, the authors assessed ED LOS and frequency of testing (blood test, urinalysis, electrocardiogram
[ECG], radiograph, ultrasound, computed tomography [CT], or magnetic resonance imaging [MRI]) and
treatment (providing a medication or performance of a procedure) according to disposition (discharged or
admitted status). Two sets of multivariable models were developed to assess the contribution of testing and
treatment to LOS, also stratified by disposition. The first was a series of logistic regression models to pro-
vide an overview of how testing and treatment activity affects three dichotomized LOS cutoffs at 2, 4, and
6 hours. The second was a generalized linear model (GLM) with a log-link function and gamma distribution
to fit skewed LOS data, which provided time costs associated with tests and treatment.
Results: Among 360 million weighted ED visits included in this analysis, 227 million (63%) involved test-
ing, 304 million (85%) involved treatment, and 201 million (56%) involved both. Overall, visits with any
testing were associated with longer LOS (median = 196 minutes; interquartile range [IQR] = 125 to
305 minutes) than those with any treatment (median = 159 minutes; IQR = 91 to 262 minutes). This differ-
ence was more pronounced among discharged patients than admitted patients. Obtaining a test was
associated with an adjusted odds ratio (OR) of 2.29 (95% confidence interval [CI] = 1.86 to 2.83) for expe-
riencing a more than 4-hour LOS, while performing a treatment had no effect (adjusted OR = 0.84; 95%
CI = 0.68 to 1.03). The most time-costly testing modalities included blood test (adjusted marginal effects
on LOS = +72 minutes; 95% CI = 66 to 78 minutes), MRI (+64 minutes; 95% CI = 36 to 93 minutes), CT
(+59 minutes; 95% CI = 54 to 65 minutes), and ultrasound (US; +56 minutes; 95% CI = 45 to 67 minutes).
Treatment time costs were less substantial: performing a procedure (+24 minutes; 95% CI = 20 to
28 minutes) and providing a medication (+15 minutes; 95% CI = 8 to 21 minutes).
Conclusions: Testing and less substantially treatment were associated with prolonged LOS in the ED,
particularly for blood testing and advanced imaging. This knowledge may better direct efforts at stream-
lining delivery of care for the most time-costly diagnostic modalities or suggest areas for future research
into improving processes of care. Developing systems to improve efficient utilization of these services in
the ED may improve patient and provider satisfaction. Such practice improvements could then be
examined to determine their effects on ED crowding.
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Testing and treatment have always been routineand important aspects of emergency care, but inrecent years the emergency department’s (ED)
role in delivering more intensive services has expanded.
Given that both the use of testing and the treatment are
largely controlled by the ED, an improved recognition of
how these factors influence length of stay (LOS) and
potentially ED crowding could help providers and
policy-makers design systems that allow services to be
performed more efficiently in this environment. In addi-
tion, knowledge of the time costs related to testing and
treatment have implications for providers and patients
regarding expectations for ED length of visit,1,2 adminis-
trators planning efficient operations and appropriate ED
staffing models,3,4 and researchers attempting to create
better models to predict ED flow.5–7
Previous studies of prolonged patient LOS in the ED
have focused appropriately on understanding the con-
tribution of patient and visit-related factors8,9 or have
evaluated this topic at only one ED,10 which limits the
generalizability of results. While these assessments pro-
vide some explanation for factors effecting ED LOS,
they have not accounted for recent changes in the com-
plexity of care delivered in this setting. In addition, ED
LOSs have been steadily increasing over the past dec-
ade,11,12 and previous assessments may not reflect the
current state of affairs.
We therefore examined national practice patterns in
common diagnostic tests, advanced imaging studies,
and treatment (performing a procedure or administer-
ing a medication), using a recent 3-year period of data
from the National Hospital Ambulatory Medical Care
Survey (NHAMCS), a large nationwide study of ED care
across the United States.13 Our goals were to evaluate
the effect these practices had on ED LOS and to deter-
mine the extent to which current diagnostic testing and
treatment patterns contribute to longer patient LOS.
METHODS
Study Design
We performed a secondary analysis of the ED compo-
nent of the NHAMCS. The Institutional Review Board
of the University of Michigan evaluated this study prior
to its initiation and determined it to be exempt from
further review or informed consent requirements.
Study Setting and Population
We were interested in studying current testing and
treatment patterns and therefore combined and
analyzed the recent survey years of 2006 through
2008. Combining survey years incrementally improves
the associated standard error of the estimates and
ensures an adequate sampling of events.14 NHAMCS
is directed by the Centers for Disease Control and
Prevention (CDC) and the National Center for Health
Statistics. This survey collects a nationally representa-
tive sample of all ED visits in noninstitutional general
and short-stay hospitals, excluding federal, military,
and Veterans Administration hospitals. Staff at
the sampled hospitals, under guidance of NHAMCS
field representatives, collected information on patient
demographics, visit characteristics, and hospital
factors for all ED visits during a randomly assigned
4-week reporting period each year. A detailed
description of the data collection, abstraction, and
cleaning procedures is available from the CDC.13
These data are publicly available and anonymous.
Study Protocol
The primary outcome for this analysis was ED LOS.
The NHAMCS calculates LOS from the moment of
patient arrival until discharged or, if admitted, until the
time the patient left the ED. The sample was missing
LOS data on 5.6% of the visits, so these visits were not
included in the study cohort. Using Pearson’s chi-
square, there were no important differences among
demographic, visit, or hospital characteristics between
those visits with LOS data and those without (data not
shown, but available on request from the authors).
The primary covariate of interest for this study was
receiving a diagnostic test or treatment during an ED
visit. We included and analyzed all tests recorded in the
NHAMCS database. These tests included obtaining any
blood test, urinalysis, electrocardiogram (ECG), radio-
graph, ultrasound (US), computed tomography (CT), or
magnetic resonance imaging (MRI). The variable for
blood testing was a composite of several individual
blood tests recorded in NHAMCS, including complete
blood count, blood urea nitrogen ⁄ creatinine, electro-
lytes, glucose, liver function tests, arterial blood gas,
cardiac enzymes, prothrombin time ⁄ international nor-
malized ratio, blood alcohol level, blood culture, human
immunodeficiency virus serology, or any other blood
test. Treatment included provision of one or more med-
ications or a composite measure of performance of any
type of procedure (cardiopulmonary resuscitation,
endotracheal intubation, nasogastric tube placement,
bladder catheterization, intravenous [IV] fluids, nebu-
lizer therapy, wound care, orthopedic care, or other
procedure). To provide a general overview of testing
and treatment activity, dichotomous outcome catego-
ries of receiving any test or any treatment were cre-
ated. These composite outcomes were chosen out of
concern for ensuring an adequate sample size for the
multivariable logistic regression modeling.
Data available in the NHAMCS comprised informa-
tion on patient demographics, visit characteristics, and
hospital factors. Patient demographics included age,
sex, self-reported race (categories collapsed to white or
nonwhite, as there are few other races found in the
database and these were therefore combined with black
into a single category), ethnicity (Hispanic or non-
Hispanic), and insurance status (categories collapsed to
uninsured [self-pay, no charge, and charity combined
as there are few cases individually in these categories],
Medicaid, Medicare, and private or other insurance).
Visit characteristics included year during which the
visit occurred (considered as a categorical variable
with 2006 as the reference category), ED arrival time
(collapsed to four consecutive 6-hour blocks of time,
starting with the period with the fewest visits, from
1 AM to 7 AM, which served as the reference), wait
time (defined as time of patient arrival until seen by
provider, treated as a continuous variable in 5-minute
segments to ameliorate the effect of recorded time
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values that tend to be rounded to the nearest 5-minute
digit), day of week, season, mode of arrival (ambu-
lance, public service such as police or social services,
walk-in), triage category (recommended immediacy
with which patient should be seen of <15 minutes,
within 15 to 60 minutes, within 1 to 2 hours, within
2 to 24 hours), pain category (none, mild, moderate,
severe), specific type of tests obtained during the visit
(blood test, urinalysis, ECG, radiograph, US, CT, MRI),
specific type of treatment performed (provision of at
least one medication, performance of a procedure),
whether the patient was seen by a resident or physi-
cian extender, and disposition (categories collapsed to
left against medical advice [AMA] or prior to comple-
tion of visit [left without being seen, LWBS], died in
ED, discharged, transferred, admitted to hospital).
Hospital factors included location, region, teaching
status, and hospital ownership as provided by the
NHAMCS database. Location was determined by
metropolitan statistical areas as urban or rural. Region
was divided into areas of South, Northeast, West, and
Midwest, according to the U.S. Census Bureau. To
adjust for differences between hospitals that were
purely nonteaching versus those that engaged in some
degree of teaching, hospitals were characterized as a
teaching institution if at least one of the ED visits
involved a resident or intern during the sample period.
Hospital ownership was divided into government (non-
federal), for-profit, and nonprofit.
Data Analysis
All analyses used weights, strata, and primary sampling
unit design variables provided by the NHAMCS to gen-
erate national estimates.13 Results were stratified by
disposition, to determine if there were disproportionate
effects on patient LOS for those who were discharged
versus admitted. Discharge was defined as all patients
who were discharged home at the end of the visit.
Admission was defined as visits ending in hospitaliza-
tion, either to an intensive care unit or to a general
bed. ED visits could also end in transfer, LWBS, left
AMA, or died in ED, with these visits being excluded
from the disposition aspect of the analysis. Descriptive
statistics present median ED LOS with interquartile
ranges (IQRs) across testing and treatment modalities
stratified by disposition, as well as testing and
treatment utilization across patient demographics, visit
characteristics, and hospital factors.
To assess the contribution of testing and treatment to
ED LOS, two types of multivariable models were con-
structed. The first was a series of three logistic regres-
sion models to provide an overview of how testing and
treatment activity affects three dichotomized LOS cut-
offs for all ED patients. These models were constructed
to evaluate the odds of experiencing a LOS longer than
2, 4, and 6 hours by whether a patient received any
type of diagnostic test or treatment. A 4-hour ED LOS
corresponds to the former United Kingdom standard,15
while a 6-hour LOS corresponded to the maximum
Canadian standard.16 The second was a generalized
linear model (GLM) with a log-link function and
gamma distribution to fit skewed ED LOS data. GLM is
a form of regression analysis and is a commonly used
technique in health services and social science
research.17 As noted in previous ED time analysis stud-
ies, LOS data were not normally distributed.8,11,18–21
Therefore, this approach was used to allow appropriate
modeling of these time data with the ability to report
the results in the original time units as opposed to a
log-transformed outcome. This model was constructed
to determine the contribution of individual tests and
treatment to ED LOS, with LOS treated as a continuous
variable.
Variables were selected as covariates in the models
based on their a priori clinical importance and hypoth-
esized effect on ED LOS. We also tested these
assumptions by exploring the relationships between
these covariates, the predictor (individual test or treat-
ment modality), and outcome (ED LOS). All covariates
were related to both the test or treatment and out-
come on univariate analysis at a p-value of less than
0.05. In addition, the models were tested for collinear-
ity by measuring the variance inflation factor. We
planned a priori to remove all covariates with an infla-
tion factor of more than 10, but there were none that
fit that criterion. Given the large number of covariates
used in these models, we also adjusted the p-value for
multiple comparisons using the Bonferroni correction
from a level of 0.05. We did this to ensure that the
relationship was clearly associated with the outcome
of interest. However, if the outcome was still statisti-
cally significant after this adjustment, we reported at
the 95% confidence interval (CI). All main outcomes
were statistically significant after this adjustment for
multiple comparisons.
The three final logistic regression models exploring
the relationship between ED LOS at cutoffs of 2, 4, and
6 hours, and testing and treatment included the covari-
ates of year of study, age, sex, race, ethnicity, insur-
ance, arrival time, wait time, day of week, season, mode
of arrival, triage category, pain category, if any test
was done, if any treatment was performed, if seen by a
physician extender or resident, disposition, hospital
location, region, type, and ownership. In addition, inter-
action terms were included to take into account any
multiplicative effects between arrival time and wait time
and testing and treatment modalities. The final GLM
analyzing the contribution of individual tests and treat-
ment to ED LOS included all of the above covariates,
except in place of the covariates for any test or any
treatment, variables were utilized for specific types of
tests obtained (blood test, urinalysis, ECG, radiograph,
US, CT, MRI) and specific categories of treatments per-
formed (medication or procedure), as well as interac-
tion terms between different types of testing and
treatment modalities.
In addition, we calculated a Harrell’s C-statistic22 for
these models. This statistic provides a measure of
the predictive accuracy of the model, similar to the
area under the receiver operator curve (ROC). The
C-statistic ranges from 0.5 (no predictive ability) to 1
(perfect discrimination), and, for this model, is based
on a comparison of the predictive probabilities in ED
encounters with and without the outcome of receiving
the test or treatment. The C-statistic illustrates how
well the model discriminates between patients who
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had a test or treatment and those that did not. Values
greater than 0.80 reflect good discriminatory power.
The final logistic regression models provided very
good concordance with the predicted probabilities,
with associated Harrell’s C-statistics of 0.85 (95%
CI = 0.84 to 0.86) for the 2-hour cutoff model, 0.83
(95% CI = 0.82 to 0.84) for the 4-hour cutoff model,
and 0.80 (95% CI = 0.79 to 0.82) for the 6-hour cutoff
model. The final GLM provided moderate concordance
with the predicted probabilities, with an associated
Harrell’s C-statistic of 0.77 (95% CI = 0.76 to 0.78).
Results from this model were reported as the average
marginal effects on LOS of receiving a test or proce-
dure, stratified by disposition. The result is shown in
minutes with associated 95% CIs.
All statistical tests were two-tailed. Data management
and analysis were performed with Stata software (ver-
sion 11.0, StataCorp, College Station, TX) taking into
account the complex survey design of NHAMCS with
the svy package of commands.
RESULTS
Characteristics of ED Visits
The 2006 through 2008 NHAMCS data set included
information on 105,473 ED visits sampled at 364 hospi-
tals over the study period. These cases were weighted
to represent 359,755,013 visits nationally over the study
period. The distribution of ED LOS with median values
is shown in Figure 1 for all visits and discharged and
admitted patients. As is typical with LOS data, the dis-
tribution has a rightward skew. On average, discharged
patients had shorter LOS than admitted patients.
Characteristics of Study Subjects
Table 1 displays testing and treatment use across vari-
ous patient demographics, visit characteristics, and hos-
pital factors. Larger differences were found among
those receiving tests and treatment across categories of
age, insurance status, mode of arrival, triage, and dis-
position. Testing occurred in approximately 63% of all
ED visits and treatment in approximately 85% of all ED
visits. Figure 2 shows the frequency of testing and
treatment performed during ED visits by whether tests
were ordered, treatments provided, and disposition. In
general, across all modalities, admitted patients had
more tests and treatments performed during their ED
evaluations than discharged patients. Blood tests and
radiographs were the most frequent tests obtained.
Providing a medication was more commonly done than
performing a procedure.
Main Results
Median LOS for the different diagnostic testing and
treatment modalities by disposition is shown in
Figure 3. Those visits in which tests or treatments were
performed were associated with longer median LOS
compared to those visits in which no interventions
were done. In addition, these differences were more
pronounced among discharged patients than admitted
patients. For example, the difference in LOS between
receiving any test and receiving no tests among dis-
charged patients was 84 minutes, while this difference
was 49.5 minutes among admitted patients.
Testing and treatment were both associated with pro-
longed LOS in the ED. In Figure 4, the adjusted odds of
experiencing an ED LOS longer than 2 hours for any
test was 5.16 (95% CI = 4.21 to 6.31). While this effect
decreased at the longer cutoff points of 4- and 6-hour
LOS, it continued to persist. An ED visit associated with
any test still had an adjusted odds of 1.48 (95% CI = 1.11
to 1.96) of being longer than 6 hours. In contrast, treat-
ment exerted less of an effect. By the 4-hour mark, the
associated adjusted odds of receiving treatment and
having a longer ED visit was not significant at 0.84 (95%
CI = 0.68 to 1.03).
Figure 1. Distribution of ED visit LOS by disposition. LOS = length of stay.
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Table 1































42.1 ± 24.1 28.2 ± 21.2 37.5 ± 23.8 33.8 ± 24.8
<18 36,134,398 15.9 (15.0–16.8) 44,960,967 33.9 (32.2–35.5) 64,898,115 21.4 (20.2–22.5) 16,197,250 30.0 (26.9–31.0)
18–34 59,200,208 26.1 (25.4–26.8) 40,004,214 30.1 (29.2–31.1) 84,179,765 27.7 (27.0–28.4) 15,024,657 26.9 (25.7–28.0)
35–49 47,750,997 21.0 (20.5–21.5) 26,077,423 19.6 (19.0–20.3) 63,548,259 20.9 (20.4–21.4) 10,280,161 18.4 (17.4–19.4)
50–64 37,894,349 16.7 (16.2–17.1) 13,652,646 10.3 (9.7–10.8) 44,891,416 14.8 (14.4–15.2) 6,655,579 11.9 (11.0–12.9)
65–79 26,354,895 11.6 (11.1–12.1) 5,316,467 4.0 (3.7–4.3) 44,891,416 9.0 (8.6–9.4) 4,347,020 7.8 (7.1–8.5)
>79 19,684,634 8.7 (8.2–9.2) 2,723,815 2.1 (1.8–2.3) 18,995,590 6.3 (5.9–6.6) 3,412,859 6.1 (5.4–6.8)
Sex
Female 127,831,228 56.3 (55.7–56.9) 67,361,674 50.7 (49.9–51.6) 165,343,021 54.5 (53.9–55.0) 29,849,881 53.4 (52.4–54.4)
Male 99,188,253 43.7 (43.1–44.3) 65,373,858 49.3 (48.4–50.1) 138,494,466 45.6 (45.0–46.1) 26,067,645 46.6 (45.6–47.6)
Race
Nonwhite 59,585,894 26.2 (23.5–29.0) 40,127,937 30.2 (27.1–33.3) 82,995,943 27.3 (24.5–30.1) 16,717,888 29.9 (26.5–33.3)
White 167,433,587 73.8 (71.0–76.5) 92,607,595 69.8 (66.7–72.9) 220,841,544 72.7 (69.9–75.5) 39,199,638 70.1 (66.7–73.5)
Ethnicity
Hispanic 28,696,795 12.6 (10.8–14.5) 19,921,786 15.0 (12.8–17.2) 40,783,455 13.4 (11.5–15.4) 7,835,126 14.0 (12.0–16.1)
Non-Hispanic 198,322,686 87.4 (85.5–89.2) 112,813,746 85.0 (82.8–87.2) 263,054,032 86.6 (84.6–88.5) 48,082,400 86.0 (83.9–88.0)
Insurance
Medicaid 47,701,157 21.0 (19.8–22.2) 37,570,328 28.3 (26.6–30.0) 71,125,689 23.4 (22.1–24.7) 14,145,796 25.3 (23.5–27.1)
Uninsured 33,986,302 15.0 (13.8–16.1) 24,470,023 18.4 (17.0–19.8) 49,161,519 16.2 (15.0–17.3) 9,294,806 16.6 (15.0–18.3)
Private or
other
86,639,664 38.2 (36.9–39.4) 49,519,918 37.3 (35.4–39.2) 117,771,210 38.8 (37.4–40.1) 18,388,372 32.9 (30.9–34.8)
Medicare 46,134,626 20.3 (19.4–21.2) 10,102,047 7.6 (7.0–8.2) 48,257,042 15.9 (15.1–16.6) 7,979,631 14.3 (13.1–15.5)
Visit characteristics
ED arrival time
1 AM–7 AM 21,916,026 9.7 (9.2–10.1) 12,035,602 9.1 (8.6–9.5) 29,115,532 9.6 (9.2–9.9) 4,836,096 8.6 (8.0–9.3)
7 AM–1 PM 66,438,607 29.3 (28.7–29.8) 35,134,727 26.5 (25.8–27.2) 86,333,024 28.4 (27.9–28.9) 15,240,310 27.3 (26.1–28.4)
1 PM–7 PM 77,826,349 34.3 (33.8–34.7) 45,346,929 34.2 (33.3–35.0) 104,196,725 34.3 (33.8–34.7) 18,976,553 33.9 (32.8–35.0)
7 PM–1 AM 59,271,844 26.1 (25.6–26.6) 38,056,521 28.7 (27.9–29.5) 81,871,063 26.9 (26.5–27.4) 15,457,302 27.6 (26.7–28.6)
Day of week
Monday 34,584,840 15.2 (15.0–15.5) 20,192,902 15.2 (14.8–15.6) 45,876,533 15.1 (14.9–15.3) 8,901,209 15.9 (15.1–16.7)
Tuesday 33,169,267 14.6 (14.3–14.9) 18,503,462 13.9 (13.5–14.4) 43,652,980 14.4 (14.2–14.6) 8,019,749 14.3 (13.7–15.0)
Wednesday 31,956,653 14.1 (13.8–14.3) 18,549,359 14.0 (13.6–14.4) 42,394,057 14.0 (13.8–14.2) 8,111,955 14.5 (13.8–15.2)
Thursday 31,594,530 13.9 (13.7–14.2) 17,714,988 13.3 (13.0–13.7) 41,516,574 13.7 (13.5–13.8) 7,792,944 13.9 (13.3–14.5)
Friday 31,603,365 13.9 (13.7–14.2) 17,764,813 13.4 (13.0–13.7) 41,401,263 13.6 (13.4–13.8) 7,966,915 14.2 (13.6–14.9)
Saturday 31,792,795 14.0 (13.7–14.3) 19,824,215 14.9 (14.4–15.5) 44,146,942 14.5 (14.3–14.7) 7,470,068 13.4 (12.6–14.1)
Sunday 32,318,031 14.2 (14.0–14.5) 20,185,793 15.2 (14.8–15.6) 44,849,138 14.8 (14.5–15.0) 7,654,686 13.7 (13.0–14.4)
Season
Winter 58,463,584 25.8 (22.9–28.6) 33,934,398 25.6 (22.5–28.6) 78,524,634 25.8 (23.0–28.7) 13,873,348 24.8 (21.6–28.0)
Spring 59,113,336 26.0 (23.3–28.8) 34,732,460 26.2 (23.3–29.1) 78,190,848 25.7 (23.0–28.5) 15,654,948 28.0 (24.8–31.2)
Summer 58,630,305 25.8 (23.2–28.5) 33,412,053 25.2 (22.4–27.9) 78,662,471 25.9 (23.2–28.6) 13,379,887 23.9 (21.1–26.7)
Fall 50,812,256 22.4 (19.6–25.2) 30,656,621 23.1 (20.1–26.1) 68,459,534 22.5 (19.7–25.3) 13,009,343 23.3 (20.0–26.5)
Mode of arrival
Ambulance 47,896,843 21.1 (20.1–22.1) 8,102,162 6.1 (5.4–6.8) 47,909,565 15.8 (14.8–16.7) 8,089,440 14.5 (13.3–15.6)
Public service 3,930,837 1.7 (1.3–2.1) 2,290,889 1.7 (1.2–2.3) 4,662,566 1.5 (1.1–1.9) 1,559,160 2.8 (2.2–3.4)
Walk-in 164,160,873 72.3 (71.0–73.6) 113,891,930 85.8 (84.3–87.3) 236,455,085 77.8 (76.5–79.1) 41,597,718 74.4 (72.3–76.5)
Triage category
<15 minutes 41,272,650 18.2 (16.5–19.9) 10,736,161 8.1 (6.9–9.3) 45,411,481 14.9 (13.5–16.4) 6,597,330 12.0 (10.4–13.2)
Within
15–60 minutes
96,674,390 42.6 (40.3–44.8) 39,984,876 30.1 (27.2–33.1) 117,502,648 38.7 (36.2–41.2) 19,156,618 34.3 (31.8–36.7)
Within
1–2 hours
40,157,070 17.7 (16.3–19.1) 36,752,195 27.7 (25.4–30.0) 65,414,499 21.5 (19.8–23.2) 11,494,766 20.6 (19.0–22.2)
Within
2–24 hours
14,441,800 6.4 (5.3–7.4) 19,135,392 14.4 (12.8–16.1) 27,499,180 9.1 (7.8–10.3) 6,078,012 10.9 (9.7–12.1)
Pain category
None 42,478,283 18.7 (17.8–19.6) 29,034,581 21.9 (20.6–23.1) 54,887,068 18.1 (17.2–19.0) 16,625,796 29.7 (28.1–31.4)
Mild 27,233,933 12.0 (11.3–12.7) 18,436,289 13.9 (13.0–14.8) 38,811,689 12.8 (12.1–13.5) 6,858,533 12.3 (11.2–13.3)
Moderate 57,738,728 25.4 (24.3–26.6) 26,468,465 19.9 (18.5–21.4) 75,214,656 24.8 (23.5–26.0) 8,992,537 16.1 (14.8–17.3)
Severe 54,471,542 24.0 (22.7–25.3) 24,286,308 18.3 (16.9–19.7) 73,002,476 24.0 (22.6–25.4) 5,755,374 10.3 (9.3–11.3)
Seen by physician extender
Yes 25,692,398 11.3 (9.7–12.9) 19,736,837 85.1 (83.1–87.1) 40,316,971 13.3 (11.5–15.0) 5,112,264 9.1 (7.7–10.6)
No 201,327,083 88.7 (87.1–90.3) 112,998,695 14.9 (12.9–16.9) 263,520,516 86.7 (85.0–88.5) 50,805,262 90.9 (89.4–92.3)
Seen by resident
Yes 22,511,675 9.9 (8.1–11.7) 9,501,352 7.2 (5.8–8.5) 28,040,954 9.2 (7.5–10.9) 3,972,073 7.1 (5.7–8.5)
No 204,507,806 90.1 (88.3–91.9) 123,234,180 92.8 (91.5–94.2) 275,796,533 90.8 (89.1–92.5) 51,945,453 92.9 (91.5–94.3)
Disposition
AMA or LWBS 3,147,601 1.4 (1.2–1.6) 9,275,107 7.0 (6.2–7.7) 2,312,232 0.8 (0.7–0.8) 10,110,476 18.1 (16.6–19.6)
Died in ED 157,757 0.1 (0.0–0.1) 212,259 0.1 (0.1–0.2) 258,746 0.1 (0.1–0.1) 111,270 0.2 (0.1–0.3)
Discharged 169,056,108 74.4 (73.1–75.7) 117,841,478 88.6 (87.5–89.7) 249,253,438 81.9 (80.9–83.0) 37,644,148 67.1 (65.1–69.1)
Transferred 5,424,324 2.4 (2.1–2.7) 724,618 0.5 (0.4–0.7) 4,800,514 1.6 (1.3–1.8) 1,348,428 2.4 (2.0–2.8)
Admitted 47,846,002 21.1 (19.8–22.4) 3,050,863 23.0 (18.8–27.2) 45,030,774 14.8 (13.8–15.9) 5,866,091 10.5 (9.1–11.9)
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Similar to the results of the logistic regression model,
the GLM also demonstrated that diagnostic tests were
associated with longer LOS than treatments. Table 2
shows the adjusted average marginal effects of differ-
ent diagnostic testing and treatment modalities. Most
testing modalities affected overall LOS to a greater
degree than treatment, with blood tests and advanced
imaging having the largest effect. The contribution of
testing to ED LOS was exerted differentially on patients
who were ultimately discharged compared to those
who were admitted (Table 2). In general, testing tended
to prolong the LOS of discharged patients more than it
did that of admitted patients. For example, the average
marginal contribution of blood testing to the LOS of a
discharged patient was +71 minutes (95% CI = 65 to
77 minutes), while for an admitted patient it was
+25 minutes (95% CI = )17 to 67 minutes).
In comparison, treatment had less of an effect on
LOS. In Table 2, the adjusted marginal effects for per-
forming a procedure and for providing a medication
were significantly less than for most testing modalities.
However, for admitted patients, administration of medi-
cations influenced LOS more significantly.
DISCUSSION
We found a significant effect of diagnostic testing on





























Urban 192,945,437 85.0 (77.5–92.4) 110,676,658 83.4 (75.2–91.6) 255,540,076 84.1 (76.3–91.9) 48,082,019 86.0 (78.7–93.3)
Rural 34,074,044 15.0 (7.6–22.5) 22,058,874 16.6 (8.4–24.8) 48,297,411 15.9 (8.1–23.7) 7,835,507 14.0 (6.7–21.3)
Region
Northeast 42,444,100 18.7 (16.1–21.3) 25,238,044 19.0 (16.3–21.8) 56,468,338 18.6 (16.1–21.1) 11,213,806 20.1 (16.5–23.6)
Midwest 49,905,438 22.0 (18.0–25.9) 27,896,272 21.0 (16.6–25.5) 65,952,249 21.7 (17.8–25.7) 11,849,461 21.2 (16.1–26.3)
South 93,256,476 41.1 (36.5–45.7) 54,251,911 40.9 (36.1–45.7) 124,940,399 41.1 (36.6–45.7) 22,567,988 40.4 (35.0–45.7)
West 41,413,467 18.2 (13.9–22.6) 25,349,305 19.1 (14.6–23.6) 56,476,501 18.6 (14.1–23.1) 10,286,271 18.4 (14.4–22.4)
Hospital type
Teaching 119,518,542 52.6 (47.8–57.5) 68,633,814 51.7 (46.8–56.7) 158,661,318 52.2 (47.3–57.2) 29,491,038 52.7 (47.9–57.6)
Nonteaching 107,500,939 47.4 (42.5–52.2) 64,101,718 48.3 (43.3–53.2) 145,176,169 47.8 (42.8–52.7) 26,426,488 47.3 (42.4–52.1)
Hospital ownership
Nonprofit 172,328,652 75.9 (71.1–80.7) 98,029,712 73.9 (68.6–79.1) 228,085,819 75.1 (70.1–80.0) 42,272,545 75.6 (70.5–80.7)
Government 29,783,584 13.1 (9.6–16.6) 18,814,117 14.2 (10.5–17.9) 40,816,088 13.4 (9.9–17.0) 7,781,613 13.9 (10.1–17.7)
For profit 24,907,245 11.0 (7.1–14.8) 15,891,703 12.0 (7.8–16.2) 34,935,580 11.5 (7.4–15.6) 5,863,368 10.5 (6.9–14.1)
AMA = against medical advice; LWBS = left without being seen.
*Based on study population of 105,473 ED visits, weighted to produce national estimates which are presented. All differences are statistically significant
at a level of p < 0.001 due to the large database. Percentages may not add to 100 due to rounding and ⁄ or missing data. Test refers to ED visit during
which any test (blood test, urinalysis, ECG, radiograph, US, CT, MRI) was performed. Treatment refers to ED visit during which either a medication was
provided or a procedure performed.
Figure 2. Diagnostic tests and treatment during ED visits by disposition over the study period 2006–2008. CT = computed tomog-
raphy; ECG = electrocardiogram; MRI = magnetic resonance imaging.
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effect. Blood tests and advanced imaging had the
largest effects, with these services each adding more
than 50 minutes to the average ED encounter. Given
the large numbers of patients being evaluated annually
in EDs with diagnostic testing, this finding has implica-
tions for operations management in the hospital. For
example, in this study, almost 40% of all ED patients
received blood testing and more than 13% received a
CT scan, suggesting that systems to streamline the use
of these common tests in the ED may be useful in
diminishing crowding. By comparison, treatment with a
medication or procedure had only a small effect on an
individual’s ED LOS. An additional finding of our study
was that the burden of the effect from testing activity
fell more heavily on discharged patients than admitted
patients, in part because LOS is greater for admitted
Figure 3. ED visit LOS by diagnostic test, treatment, and disposition. CT = computed tomography; ECG = electrocardiogram;
IQR = interquartile range; LOS = length of stay; MRI = magnetic resonance imaging.
Figure 4. Adjusted odds of experiencing a longer length of ED
visit by diagnostic testing and treatment. *Adjusted for year of
study, age, sex, race, ethnicity, insurance, arrival time, wait
time, day of visit, season, mode of arrival, triage category, pain
category, if seen by physician extender, if seen by resident, dis-
position, hospital location, hospital region, teaching hospital,
hospital ownership, if any test obtained, and if any treatment
performed.
Table 2














Blood test 72 (66 to 78) 71 (65 to 77) 25 ()17 to 67)
MRI 64 (36 to 93) 80 (42 to 118) 50 (2 to 99)
CT 59 (54 to 65) 60 (55 to 65) 51 (32 to 69)
Ultrasound 56 (45 to 67) 58 (47 to 69) 24 ()11 to 59)
Urinalysis 32 (26 to 38) 33 (27 to 40) 29 (10 to 47)
Radiograph 27 (22 to 31) 27 (23 to 30) 7 ()18 to 32)
ECG 12 (6 to18) 14 (9 to 19) )4 ()22 to 14)
Treatment
Procedure 24 (20 to 28) 23 (19 to 27) 7 ()18 to 32)
Medication 15 (8 to 21) 12 (7 to 17) 59 (33 to 84)
CT = computed tomography; ECG = electrocardiogram;
MRI = magnetic resonance imaging.
*Presented as the adjusted average marginal effects in min-
utes on length of visit with 95% CI compared to no testing
or treatment. Adjusted for year of study, age, sex, race, eth-
nicity, insurance, arrival time, wait time, day of visit, season,
mode of arrival, triage category, pain category, if seen by
physician extender, if seen by resident, disposition, hospital
location, hospital region, teaching hospital, hospital owner-
ship, specific types of tests obtained (blood test, urinalysis,
ECG, radiograph, ultrasound, CT, MRI), and specific treat-
ment provided (medication or procedure).
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patients who are subject to pressures external to the
ED such as boarding. Discharged patients make up the
bulk of all ED patients, constituting of about 85% over
the period 2006 to 2008 in NHAMCS, also suggesting
the importance of a patient’s disposition when evaluating
ED throughput processes.
Testing and treatment are integral and essential
aspects of the ED evaluation. As our nation’s EDs
accept a larger and larger role in managing acutely ill
patients, diagnostic testing in particular will only con-
tinue to expand as more definitive care is delivered in
this setting. Increasingly, EDs are becoming diagnostic
centers, with patients referred to the ED for rapid eval-
uation to determine if hospital admission is necessary.
It is therefore critical to understand how and under
what conditions testing might negatively affect patient
flow in the ED to design systems to improve through-
put efficiency. This is a particular worry for the ED
where the widespread and increasing availability of
diagnostic testing, such as CT scanners, creates minimal
barriers for its use23 and potentially means lower
thresholds for obtaining tests. For example, there is evi-
dence demonstrating growing use of advanced imaging
in the ED, particularly for CT.24–26 As shown in our
study, advanced imaging modalities are especially time-
costly on ED LOS. The increasingly longer median LOS
in our nation’s EDs documented in previous studies11,12
may therefore in part be related to increased volume of
testing being performed during patient evaluations.
In addition, we found that blood testing had similar
effects on LOS as some types of advanced imaging.
This result may seem surprising, but was likely
related to the model’s adjustments for ED visit char-
acteristics such as markers of illness severity and
other associated testing and treatment modalities per-
formed during the visit. Blood testing was more com-
monly performed than any other diagnostic modality
during ED evaluations and was often done in isola-
tion as the only diagnostic testing modality during a
visit, thereby contributing more significantly to LOS
in those cases. While a CT or MRI certainly adds sig-
nificantly to an ED visit, there were often many other
factors influencing total LOS in patients undergoing
those particular studies.
In our study, discharged patients tended to have their
ED LOS affected more significantly by the testing per-
formed during their visits. This result was likely related
to two factors: 1) admitted patients’ LOS depend sub-
stantially on inpatient hospital factors—such as the
availability of beds—to determine when they leave the
ED, as opposed to discharged patients who do not face
this same constraint; and 2) the standard ED practice
pattern in which results from laboratory tests and pro-
cedures are finalized before the decision is made to dis-
charge a patient from the ED. In contrast, waiting for
the results of all tests for patients who are destined to
be admitted is not always done. In both cases, the mar-
ginal contribution of testing and treatment to LOS will
be more likely to affect discharged patients compared
to admitted patients, especially as discharged patients
tend to have much shorter LOS than admitted patients.
Therefore, reducing time costs related to testing and
treatment in the presence of long waits for admission
will not have as great an effect for admitted patients in
comparison to discharged patients.
We see several next steps as necessary to better
understand the implications of our findings. First,
there has already been significant emphasis on
improving ED operations and throughput to improve
patient flow.4,7 Timeliness of care has been strongly
correlated to patient satisfaction in the ED.1,2 Given
the effect that diagnostic testing has on ED LOS, this
area is potentially ripe for system and process
improvements. For example, one of the time costs
associated with obtaining a CT scan is the need to
provide oral contrast, typically adding 1 to 2 hours to
the preparation time prior to scanning27 and affecting
ED LOS.28 There is evidence supporting the use of
noncontrast or IV contrast only CTs for the evaluation
of patients with appendicitis,29–32 a common indication
for obtaining an abdominal CT in the ED. As a result,
many institutions have already eliminated the routine
use of oral contrast for abdominal CT scans performed
in the ED.28 If such protocols are created that still pro-
vide for the necessary diagnostic information but
allow for quicker scans to be accomplished, this may
improve the LOS for individual patients requiring
these studies. Another solution may be incorporating
point-of-care testing to reduce laboratory turnaround
times, which has been shown to improve LOS in
certain patient populations.33 Adopting such protocols
may allow for improved diagnostic testing throughput
times and decrease testing’s effect on LOS.
Second, further research is needed to determine the
extent to which diagnostic testing in the ED leads to
downstream improvements in resource utilization such
as hospitalization decisions and clinical outcomes in the
ED. Diagnostic testing may contribute to longer ED
LOS, but is also influencing the emergency physician’s
decision-making regarding admissions and care
delivery. Testing, particularly with more time-costly
advanced imaging such as CT, MRI, and US, may avoid
hospitalization in certain patients if it allows ED provid-
ers to diagnose or exclude concerning disease pro-
cesses.26 If this testing pattern has developed in the ED,
then perhaps longer LOS are acceptable if the return on
the investment results in hospitalization savings. Testing
and treatment may also be contributing to better patient
outcomes, and the downsides of prolonging LOS
need to be balanced against the potential for earlier
diagnosis, timelier care delivery, and improved health.
LIMITATIONS
Our study should be interpreted in the context of sev-
eral limitations. There are many factors that may affect
ED LOS not measured in the NHAMCS database,
including important input, throughput, and output fea-
tures.34 For example, NHAMCS is not linked to inpatient
hospital administrative data. It has been shown that
inpatient level processes, such as the number of elective
surgical admissions and hospital occupancy, can affect
the LOS for admitted ED patients.35–37 In addition, input
factors such as the number and volume of patients
arriving to the ED for evaluation, or throughput factors
such as the current state of crowding in the ED at the
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time of evaluation, are likewise not recorded in NHA-
MCS. These specific features also would not be
accounted for in the multivariable modeling. We
attempted to control for some of these factors by includ-
ing time of ED arrival, day of the week, and season,
which may help adjust for some causes of fluctuation in
inpatient census.
The NHAMCS also represents national estimates of
the effect of testing and treatment on LOS. Therefore,
an individual ED’s results may not reflect the national
experience. In addition, there may be significant daily
variability in patient LOS during an ED visit, depending
on the setting and local environment, as well as vari-
ability in test performance at different EDs. This study
represents a general overview of test and treatment
performance on a national scale using composite mea-
sures for some modalities, suggesting the most time-
costly types of testing, and a priority for which might
provide the most significant time savings. However, in
a local application of these findings, it would be impor-
tant to look at the actual test performance for the indi-
vidual institution to determine the likely bottleneck to
better address the problem and make improvements to
ED throughput efficiency. In addition, some ED testing
and treatment is done sequentially in which one test
result informs the ordering of an additional test or the
performance of a treatment. This database does not
allow for the modeling of these scenarios, which may
affect the reported time costs contributed by specific
tests or treatments. Finally, given the retrospective nat-
ure of the database, this study cannot assess the appro-
priateness of testing or treatment being performed
during these visits, which is an important quality of
care consideration when evaluating the effect of these
activities on ED LOS.
CONCLUSIONS
Testing and treatment are important contributors to
length of stay in the ED and should be a factor in the
analysis of patient throughput and potential causes of
ED crowding. We found that diagnostic testing, espe-
cially due to blood tests and advanced imaging, can sig-
nificantly prolong length of stay. This knowledge may
better direct efforts at streamlining delivery of care for
the most time-costly diagnostic modalities or suggest
areas for future research into improving processes of
care. Development of innovative ED operations is
needed to ameliorate testing’s effect on length of stay
while also determining how testing can be better opti-
mized for use in this setting. Efficient utilization of
these services in the ED may improve patient and pro-
vider satisfaction. Such practice improvements could
then be examined to determine their effect on ED
crowding.
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